Alps Advisors Inc Gritstone Bio, Inc. Transaction History

Alps Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$2.13 - $3.74 $2,426 - $4,259	1,139 Added 2.01%	57,751 $160,000
Q4 2022 Feb 14, 2023	BUY	$2.17 - $3.92 $122,848 - $221,919	56,612 New	56,612 $195,000
Q2 2022 Aug 11, 2022	SELL	$1.77 - $4.34 $132,259 - $324,297	-74,723 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.03 - $12.19 $15,938 - $48,211	-3,955 Reduced 5.03%	74,723 $308,000
Q4 2021 Feb 09, 2022	BUY	$8.76 - $13.71 $689,219 - $1.08 Million	78,678 New	78,678 $1.01 Million

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.